tiprankstipranks
Harvard Bioscience (HBIO)
:HBIO
US Market

Harvard Bioscience (HBIO) Financial Statements

Compare
190 Followers

Harvard Bioscience Financial Overview

Harvard Bioscience's market cap is currently $20.86M. The company's EPS TTM is $-0.285; its P/E ratio is ―; Harvard Bioscience is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 94.14M$ 112.25M$ 113.33M$ 118.90M$ 102.10M
Gross Profit$ 54.77M$ 66.07M$ 60.82M$ 67.65M$ 58.04M
Operating Income$ -6.21M$ 1.89M$ -7.17M$ 1.40M$ -585.00K
EBITDA$ -1.30M$ 8.03M$ 944.00K$ 11.31M$ 5.49M
Net Income$ -12.40M$ -3.42M$ -9.52M$ -288.00K$ -7.81M
Balance Sheet
Cash & Short-Term Investments$ 4.11M$ 4.28M$ 4.51M$ 7.82M$ 8.32M
Total Assets$ 126.64M$ 137.37M$ 145.36M$ 162.34M$ 156.25M
Total Debt$ 44.49M$ 42.77M$ 46.82M$ 48.33M$ 48.01M
Net Debt$ 40.39M$ 38.49M$ 42.32M$ 40.51M$ 39.69M
Total Liabilities$ 63.30M$ 64.29M$ 73.14M$ 78.94M$ 79.57M
Stockholders' Equity$ 63.34M$ 73.07M$ 72.22M$ 83.40M$ 76.68M
Cash Flow
Free Cash Flow$ -1.20M$ 11.72M$ -438.00K$ -83.00K$ 8.18M
Operating Cash Flow$ 1.44M$ 14.03M$ 1.15M$ 1.26M$ 9.33M
Investing Cash Flow$ -1.34M$ -1.80M$ -1.59M$ -1.34M$ -1.40M
Financing Cash Flow$ -131.00K$ -12.13M$ -2.84M$ -252.00K$ -7.97M
Currency in USD

Harvard Bioscience Earnings and Revenue History

Harvard Bioscience Debt to Assets

Harvard Bioscience Cash Flow

Harvard Bioscience Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis